ClinicalTrials.Veeva

Menu

Global Evaluation of Cholecystectomy Knowledge and Outcomes, Indonesia (GECKO-ID)

U

Udayana University

Status

Completed

Conditions

Cholecystectomy

Study type

Observational

Funder types

Other

Identifiers

NCT06183346
GECKO-INDONESIA

Details and patient eligibility

About

GECKO is a prospective, international, multicentre, observational cohort study delivered by GlobalSurg Collaborative. This will be on consecutive patients undergoing cholecystectomy, between 31st July 2023 to 19th November 2023, with follow-up at 30-day and one-year postoperatively. Mini-teams of up to five collaborators per 14-day data collection period will prospectively collect data at each participating centre.

The primary aim is to define the global variation in compliance to pre-, intra-, and post-operative audit standards. The subjects will be observed and interviewed during pre-surgery hospitalization up to one-year post-surgery.

Full description

Audit Standards include:

  1. Pre-operative

    • Interventional radiology service
    • Risk Stratification (Tokyo Guidelines).
    • Timing of surgery
  2. Intraoperative

    • Critical Safety View (CVS)
    • Intraoperative imaging
    • Bailout Procedures
    • Antibiotic use
    • Use of drains
    • Bile Duct Injury (BDI)
  3. Postoperative

    • 30-day readmission
    • Critical Care

Enrollment

92 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • All adult patients (greater than or including 18 years of age)
  • Undergo primary cholecystectomy (as the main procedure)
  • Any open, laparoscopic, robotic approaches are eligible
  • Elective, delayed and emergency cholecystectomy

Exclusion criteria

  • Cholecystectomy as a part of another surgical procedure (Whipple's, bariatric, transplant)
  • Patients with Mirizzi syndrome
  • Patients returning to theatre and requiring a cholecystectomy for whatever indication
  • Known gallbladder malignancy: Gallbladder cancer diagnosed preoperatively

Trial design

92 participants in 1 patient group

Main Cohort (Single Cohort)
Description:
The main cohort consists of all patients who will undergo either emergency/urgent/delayed/elective cholecystectomy in all participating hospitals in Indonesia. Inclusion/exclusion criteria will be applied.

Trial contacts and locations

2

Loading...

Central trial contact

Christopher Ryalino

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems